A Phase Iv Study Using Multi-Omits To Identify Mechanisms Of Response And Resistance To Crizotinib In Alk Plus Advanced Non-Small Cell Lung Cancer (Nsclc) Patients With Distinct Progression Free Survival Outcomes.
JOURNAL OF CLINICAL ONCOLOGY（2017）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要